Case Reports in Medicine
Volume 2012 (2012), Article ID 468452, 12 pages
http://dx.doi.org/10.1155/2012/468452
Case Report
An Unusual Presentation of Tumor Lysis Syndrome in a Patient with Advanced Gastric Adenocarcinoma: Case Report and Literature Review
Department of Nephrology and Hypertension, Jackson Memorial Hospital, 1611 North West 12th Avenue, Miami, FL 33101, USA
Received 28 November 2011; Revised 22 February 2012; Accepted 13 March 2012
Academic Editor: Glenn Bubley
Copyright © 2012 Danica Maria Vodopivec et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- R. Larson and C. H. Pui, “Tumor lysis syndrome,” 2011, http://www.uptodate.com/contents/tumor-lysis-syndrome?source=search_result&search=tumor+lysis+syndrome&selectedTitle=1~58.
- S. C. Howard, D. P. Jones, and C. H. Pui, “The tumor lysis syndrome,” New England Journal of Medicine, vol. 364, no. 19, pp. 1844–1854, 2011. View at Publisher · View at Google Scholar · View at Scopus
- C. Gemici, “Tumour lysis syndrome in solid tumours,” Clinical Oncology, vol. 18, no. 10, pp. 773–780, 2006. View at Publisher · View at Google Scholar · View at Scopus
- M. S. Cairo and M. Bishop, “Tumour lysis syndrome: new therapeutic strategies and classification,” British Journal of Haematology, vol. 127, no. 1, pp. 3–11, 2004. View at Publisher · View at Google Scholar · View at Scopus
- M. B. Davidson, S. Thakkar, J. K. Hix, N. D. Bhandarkar, A. Wong, and M. J. Schreiber, “Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome,” American Journal of Medicine, vol. 116, no. 8, pp. 546–554, 2004. View at Publisher · View at Google Scholar · View at Scopus
- T. I. Mughal, A. A. Ejaz, J. R. Foringer, and B. Coiffier, “An integrated clinical approach for the identification, prevention, and treatment of tumor lysis syndrome,” Cancer Treatment Reviews, vol. 36, no. 2, pp. 164–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
- B. Coiffier, A. Altman, C. H. Pui, A. Younes, and M. S. Cairo, “Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review,” Journal of Clinical Oncology, vol. 26, no. 16, pp. 2767–2778, 2008. View at Publisher · View at Google Scholar · View at Scopus
- B. Coiffier, “Acute tumor lysis syndrome—a rare complication in the treatment of solid tumors,” Onkologie, vol. 33, no. 10, pp. 498–499, 2010. View at Publisher · View at Google Scholar · View at Scopus
- B. Jallad, T. Hamdi, S. Latta, M. N. Alhosaini, F. Kheir, and N. Iroegbu, “Tumor lysis syndrome in small cell lung cancer: a case report and review of the literature,” Onkologie, vol. 34, no. 3, pp. 129–131, 2011. View at Publisher · View at Google Scholar · View at Scopus
- C. Shenoy, “Acute spontaneous tumor lysis syndrome in a patient with squamous cell carcinoma of the lung,” QJM, vol. 102, no. 1, pp. 71–73, 2009. View at Publisher · View at Google Scholar · View at Scopus
- M. Abboud and A. Shamseddine, “Maxillary sinus squamous cell carcinoma presenting with fatal tumor lysis syndrome: a case report and review of the literature,” Case Reports in Oncology, vol. 2, pp. 229–233, 2009. View at Google Scholar
- J. Feld, H. Mehta, and R. L. Burkes, “Acute spontaneous tumor lysis syndrome in adenocarcinoma of the lung: a case report,” American Journal of Clinical Oncology, vol. 23, no. 5, pp. 491–493, 2000. View at Publisher · View at Google Scholar · View at Scopus
- D. R. Crittenden and G. L. Ackerman, “Hyperuricemic acute renal failure in disseminated carcinoma,” Archives of Internal Medicine, vol. 137, no. 1, pp. 97–99, 1977. View at Publisher · View at Google Scholar · View at Scopus
- I. S. Woo, J. S. Kim, M. J. Park et al., “Spontaneous acute tumor lysis syndrome with advanced gastric cancer,” Journal of Korean Medical Science, vol. 16, no. 1, pp. 115–118, 2001. View at Google Scholar · View at Scopus
- E. Vaisban, A. Braester, O. Mosenzon, M. Kolin, and Y. Horn, “Spontaneous tumor lysis syndrome in solid tumors: really a rare condition?” American Journal of the Medical Sciences, vol. 325, no. 1, pp. 38–40, 2003. View at Publisher · View at Google Scholar · View at Scopus
- N. T. Sklarin and M. Markham, “Spontaneous recurrent tumor lysis syndrome in breast cancer,” American Journal of Clinical Oncology, vol. 18, no. 1, pp. 71–73, 1995. View at Google Scholar · View at Scopus
- G. Pentheroudakis, V. O'Neill, P. Vasey, and S. Kaye, “Spontaneous acute tumour lysis syndrome in patients with metastatic germ cell tumours: report of two cases,” Supportive Care in Cancer, vol. 9, no. 7, pp. 554–557, 2001. View at Publisher · View at Google Scholar · View at Scopus
- V. D'Alessandro, A. Greco, C. Clemente et al., “Severe spontaneous acute tumor lysis syndrome and hypoglycemia in patient with germ cell tumor,” Tumori, vol. 96, no. 6, pp. 1040–1043, 2010. View at Google Scholar · View at Scopus
- E. Bien, L. MacIejka-Kapuscinska, M. Niedzwiecki et al., “Childhood rhabdomyosarcoma metastatic to bone marrow presenting with disseminated intravascular coagulation and acute tumour lysis syndrome: review of the literature apropos of two cases,” Clinical and Experimental Metastasis, vol. 27, no. 6, pp. 399–407, 2010. View at Publisher · View at Google Scholar · View at Scopus
- N. J. Vogelzang, R. A. Nelimark, and K. A. Nath, “Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma,” Journal of the American Medical Association, vol. 249, no. 4, pp. 513–514, 1983. View at Publisher · View at Google Scholar · View at Scopus
- M. A. Baumann, J. C. Frick, P. Y. Holoye, and N. J. Vogelzang, “The tumor lysis syndrome,” Journal of the American Medical Association, vol. 250, no. 5, p. 615, 1983. View at Publisher · View at Google Scholar · View at Scopus
- N. Heching and P. Bonomi, “Tumor lysis syndrome in metastatic small cell cancer,” Proceedings of the American Association for Cancer Research, vol. 29, p. 179, 1988. View at Google Scholar
- A. M. Hussein and L. G. Feun, “Tumor lysis syndrome after induction chemotherapy in small-cell lung carcinoma,” American Journal of Clinical Oncology, vol. 13, no. 1, pp. 10–13, 1990. View at Google Scholar · View at Scopus
- L. Y. Dirix, A. Prove, D. Becquart, E. Wouters, P. Vermeulen, and A. Van Oosterom, “Tumor lysis syndrome in a patient with metastatic Merkel cell carcinoma,” Cancer, vol. 67, no. 8, pp. 2207–2210, 1991. View at Google Scholar · View at Scopus
- T. Ohnishi, K. Mori et al., “Tumor lysis syndrome in widely metastasic small-cell lung cancer,” International Journal of Clinical Oncology, vol. 2, pp. 235–237, 1997. View at Google Scholar
- G. P. Kalemkerian, B. Darwish, and M. L. Varterasian, “Tumor lysis syndrome in small cell carcinoma and other solid tumors,” American Journal of Medicine, vol. 103, no. 5, pp. 363–367, 1997. View at Publisher · View at Google Scholar · View at Scopus
- M. A. Marinella, “Fatal tumor lysis syndrome and gastric hemorrhage associated with metastatic small-cell lung carcinoma,” Medical and Pediatric Oncology, vol. 32, pp. 464–465, 1999. View at Google Scholar
- A. M. Kallab and A. P. Jillella, “Tumor lysis syndrome in small cell lung cancer,” Medical Oncology, vol. 18, no. 2, pp. 149–151, 2001. View at Publisher · View at Google Scholar · View at Scopus
- S. Beriwal, S. Singh, and J. A. Garcia-Young, “Tumor lysis syndrome in extensive-stage small-cell lung cancer,” American Journal of Clinical Oncology, vol. 25, no. 5, pp. 474–475, 2002. View at Publisher · View at Google Scholar · View at Scopus
- F. E. Mott, A. Esana et al., “Tumor lysis syndrome in solid tumors,” Supportive Cancer Therapy, vol. 2, pp. 188–191, 2005. View at Google Scholar
- D. A. Persons, J. Garst, R. Vollmer, and J. Crawford, “Tumor lysis syndrome and acute renal failure after treatment of non- small-cell lung carcinoma with combination irinotecan and cisplatin,” American Journal of Clinical Oncology, vol. 21, no. 4, pp. 426–429, 1998. View at Publisher · View at Google Scholar · View at Scopus
- M. Kurt, I. K. Onal, T. Elkiran, B. Altun, K. Altundag, and I. Gullu, “Acute tumor lysis syndrome triggered by zoledronic acid in a patient with metastatic lung adenocarcinoma,” Medical Oncology, vol. 22, no. 2, pp. 203–206, 2005. View at Publisher · View at Google Scholar · View at Scopus
- D. Ajzensztejn, V. S. Hegde, and M. L. Siow, “Tumor lysis syndrome after treatment with docetaxel for non-small-cell lung cancer,” Journal of Clinical Oncology, vol. 24, no. 15, pp. 2389–2391, 2006. View at Publisher · View at Google Scholar · View at Scopus
- H. H. Sewani and J. T. Rabatin, “Acute tumor lysis syndrome in a patient with mixed small cell and non-small cell tumor,” Mayo Clinic Proceedings, vol. 77, no. 7, pp. 722–728, 2002. View at Google Scholar · View at Scopus
- P. J. Saylor and T. R. Reid, “Tumor lysis syndrome after treatment of a gastrointestinal stromal tumor with the oral tyrosine kinase inhibitor sunitinib,” Journal of Clinical Oncology, vol. 25, no. 23, pp. 3544–3546, 2007. View at Publisher · View at Google Scholar · View at Scopus
- E. M. Pinder, G. S. S. Atwal, A. A. Ayantunde et al., “Tumour lysis syndrome occurring in a patient with metastatic gastrointestinal stromal tumour treated with glivec (imatinib mesylate, gleevec, STI571),” Sarcoma, vol. 2007, Article ID 82012, 2007. View at Publisher · View at Google Scholar · View at Scopus
- H. S. Han, R. P. Sook, Y. K. Sun et al., “Tumor lysis syndrome after capecitabine plus cisplatin treatment in advanced gastric cancer,” Journal of Clinical Oncology, vol. 26, no. 6, pp. 1006–1008, 2008. View at Publisher · View at Google Scholar · View at Scopus
- M. Boisseau, R. Bugat, and M. Mahjoubi, “Rapid tumour lysis syndrome in a metastatic colorectal cancer increased by treatment with irinotecan (CPT-11),” European Journal of Cancer, vol. 32, no. 4, pp. 737–738, 1996. View at Google Scholar · View at Scopus
- Z. Nikolic-Tomasevic, S. Jelic, I. Popov, and D. Radosavljevic, “Irinotecan as second-line treatment in metastatic colorectal cancer: dilemmas regarding patient selection and toxicity prediction,” Journal of Chemotherapy, vol. 12, no. 3, pp. 244–251, 2000. View at Google Scholar · View at Scopus
- I. Oztop, B. Demirkan, A. Yaren et al., “Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan,” Tumori, vol. 90, no. 5, pp. 514–516, 2004. View at Google Scholar · View at Scopus
- G. Krishnan, K. D'Silva, and A. Al-Janadi, “Cetuximab-related tumor lysis syndrome in metastatic colon carcinoma,” Journal of Clinical Oncology, vol. 26, no. 14, pp. 2406–2408, 2008. View at Publisher · View at Google Scholar · View at Scopus
- M. Hentrich, X. Schiel et al., “Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containig therapy in a patient heavily pretrated for metastasic colon cancer,” Acta Oncologica, vol. 47, pp. 155–156, 2008. View at Google Scholar
- T. E. Lobe, M. S. Karkera, M. D. Custer, R. E. Shenefelt, and E. C. Douglass, “Fatal refractory hyperkalemia due to tumor lysis during primary resection for hepatoblastoma,” Journal of Pediatric Surgery, vol. 25, no. 2, pp. 249–250, 1990. View at Publisher · View at Google Scholar · View at Scopus
- R. S. Bercovitz, B. S. Greffe, and S. P. Hunger, “Acute tumor lysis syndrome in a 7-month-old with hepatoblastoma,” Current Opinion in Pediatrics, vol. 22, no. 1, pp. 113–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
- I. A. Burney, “Acute tumor lysis syndrome after transcatheter chemoembolization of hepatocellular carcinoma,” Southern Medical Journal, vol. 91, no. 5, pp. 467–470, 1998. View at Google Scholar · View at Scopus
- S. G. Lehner, J. E. Gould, W. E. A. Saad, and D. B. Brown, “Tumor lysis syndrome after radiofrequency ablation of hepatocellular carcinoma,” American Journal of Roentgenology, vol. 185, no. 5, pp. 1307–1309, 2005. View at Publisher · View at Google Scholar · View at Scopus
- C. C. Lee, Y. H. Wu, S. H. Chung, and W. J. Chen, “Acute tumor lysis syndrome after thalidomide therapy in advanced hepatocellular carcinoma,” Oncologist, vol. 11, no. 1, pp. 87–88, 2006. View at Publisher · View at Google Scholar · View at Scopus
- N. Sakamoto, S. Monzawa, H. Nagano et al., “Acute tumor lysis syndrome caused by transcatheter oily chemoembolization in a patient with a large hepatocellular carcinoma,” Cardiovascular and Interventional Radiology, vol. 30, pp. 508–511, 2007. View at Google Scholar
- H. Shiba, Y. Ishida, S. Wakiyama, T. Sakamoto, T. Misawa, and K. Yanaga, “Acute tumor lysis syndrome after transarterial chemoembolization for hepatocellular carcinoma,” Cancer Science, vol. 99, no. 10, pp. 2104–2105, 2008. View at Publisher · View at Google Scholar · View at Scopus
- P. M. Hsieh, K. C. Hung, and Y. S. Chen, “Tumor lysis syndrome after transarterial chemoembolization of hepatocellular carcinoma: case reports and literature review,” World Journal of Gastroenterology, vol. 15, no. 37, pp. 4726–4728, 2009. View at Publisher · View at Google Scholar · View at Scopus
- W. S. Huang and C. H. Yang, “Sorafenib induced tumor lysis syndrome in an advanced hepatocellular carcinoma patient,” World Journal of Gastroenterology, vol. 15, no. 35, pp. 4464–4466, 2009. View at Publisher · View at Google Scholar · View at Scopus
- K. Shiozawa, M. Watanabe, H. Takenaka et al., “Tumor lysis syndrome after sorafenib for hepatocellular carcinoma: a case report,” Hepato-Gastroenterology, vol. 57, no. 101, pp. 688–690, 2010. View at Google Scholar · View at Scopus
- S. Joshita, K. Yoshizawa, K. Sano et al., “A patient with advanced hepatocellular carcinoma treated with sorafenib tosylate showed massive tumor lysis with avoidance of tumor lysis syndrome,” Internal Medicine, vol. 49, no. 11, pp. 991–994, 2010. View at Publisher · View at Google Scholar · View at Scopus
- T. Nicholaou, R. Wong, and I. D. Davis, “Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate,” Lancet, vol. 369, no. 9577, pp. 1923–1924, 2007. View at Publisher · View at Google Scholar · View at Scopus
- J. Michels, N. Lassau, M. Gross-Goupil, C. Massard, A. Mejean, and B. Escudier, “Sunitinib inducing tumor lysis syndrome in a patient treated for renal carcinoma,” Investigational New Drugs, vol. 28, no. 5, pp. 690–693, 2010. View at Publisher · View at Google Scholar · View at Scopus
- E. Rodriguez-Reimundes, F. Perazzo, and A. R. Vilches, “Tumor lysis syndrome in a patient with a renal carcinoma treated with sunitinib,” Medicina, vol. 71, no. 2, pp. 158–160, 2011. View at Google Scholar · View at Scopus
- C. J. Lin, K. H. Lim, Y. C. Cheng, H. H. Chen, and C. J. Wu, “Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma,” Medical Oncology, vol. 24, no. 4, pp. 455–457, 2007. View at Publisher · View at Google Scholar · View at Scopus
- S. M. Sorscher, “Tumor lysis syndrome following docetaxel therapy for extensive metastatic prostate cancer,” Cancer Chemotherapy and Pharmacology, vol. 54, pp. 191–192, 2004. View at Google Scholar
- T. Tanvetyanon and A. M. Choudhury, “Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade,” Journal of Urology, vol. 171, no. 4, p. 1627, 2004. View at Publisher · View at Google Scholar · View at Scopus
- J. L. Wright, D. W. Lin, P. Dewan, and R. B. Montgomery, “Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer,” International Journal of Urology, vol. 12, no. 11, pp. 1012–1013, 2005. View at Publisher · View at Google Scholar · View at Scopus
- C. J. Lin, R. K. Hsieh, K. H. Lim, H. H. Chen, Y. C. Cheng, and C. J. Wu, “Fatal spontaneous tumor lysis syndrome in a patient with metastatic, androgen-independent prostate cancer,” Southern Medical Journal, vol. 100, no. 9, pp. 916–917, 2007. View at Publisher · View at Google Scholar · View at Scopus
- P. Cech, J. B. Block, L. A. Cone, and R. Stone, “Tumor lysis syndrome after tamoxifen flare,” New England Journal of Medicine, vol. 315, no. 4, pp. 263–264, 1986. View at Google Scholar · View at Scopus
- M. E. Stark, M. C. D. Dyer, and C. J. Coonley, “Fatal acute tumor lysis syndrome with metastatic breast carcinoma,” Cancer, vol. 60, no. 4, pp. 762–764, 1987. View at Google Scholar · View at Scopus
- J. C. Barton, “Tumor lysis syndrome in nonhematopoietic neoplasms,” Cancer, vol. 64, no. 3, pp. 738–740, 1989. View at Google Scholar · View at Scopus
- P. Drakos, J. Bar-Ziv, and R. Catane, “Tumor lysis syndrome in nonhematologic malignancies: report of a case and review of the literature,” American Journal of Clinical Oncology, vol. 17, no. 6, pp. 502–505, 1994. View at Google Scholar · View at Scopus
- Y. Ustundag, S. Boyacioglu, I. C. Haznedaroglu, and E. Baltali, “Acute tumor lysis syndrome associated with paclitaxel,” Annals of Pharmacotherapy, vol. 31, no. 12, pp. 1548–1549, 1997. View at Google Scholar · View at Scopus
- A. Y. Rostom, G. El-Hussainy, A. Kandil, and A. Allam, “Tumor lysis syndrome following hemi-body irradiation for metastatic breast cancer,” Annals of Oncology, vol. 11, no. 10, pp. 1349–1351, 2000. View at Publisher · View at Google Scholar · View at Scopus
- K. Mevlüt, E. Orhan, E. Huseyin, and G. Nilufer, “Tumor lysis syndrome following a single dose of capecitabine,” The Annals of Pharmacotherapy, vol. 38, article 902, 2004. View at Google Scholar
- S. F. A. Bilgrami and B. G. Fallon, “Tumor lysis syndrome after combination chemotherapy for ovarian cancer,” Medical and Pediatric Oncology, vol. 21, no. 7, pp. 521–524, 1993. View at Google Scholar · View at Scopus
- J. K. Chan, S. S. Lin, D. S. McMeekin, and M. L. Berman, “Patients with malignancy requiring urgent therapy: case 3. Tumor lysis syndrome associated with chemotherapy in ovarian cancer,” Journal of Clinical Oncology, vol. 23, no. 27, pp. 6794–6795, 2005. View at Publisher · View at Google Scholar · View at Scopus
- H. Godoy, J. P. Kesterson, and S. Lele, “Tumor lysis syndrome associated with carboplatin and paclitaxel in a woman with recurrent endometrial cancer,” International Journal of Gynecology and Obstetrics, vol. 109, no. 3, p. 254, 2010. View at Publisher · View at Google Scholar · View at Scopus
- A. I. Shamseddine, A. M. Khalil, and M. H. Wehbeh, “Acute tumor lysis syndrome with squamous cell carcinoma of the vulva,” Gynecologic Oncology, vol. 51, no. 2, pp. 258–260, 1993. View at Publisher · View at Google Scholar · View at Scopus
- A. Khalil, M. Chammas, A. Shamseddine, and M. Seoud, “Fatal acute tumor lysis syndrome following treatment of vulvar carcinoma: case report,” European Journal of Gynaecological Oncology, vol. 19, no. 4, pp. 415–416, 1998. View at Google Scholar · View at Scopus
- K. Yokoi, N. Miyazawa, Y. Kano et al., “Tumor lysis syndrome in invasive thymoma with peripheral blood T-cell lymphocytosis,” American Journal of Clinical Oncology, vol. 20, no. 1, pp. 86–89, 1997. View at Publisher · View at Google Scholar · View at Scopus
- A. D. Trobaugh-Lotrario, X. Liang, J. S. Janik, M. A. Lovell, and L. F. Odom, “Difficult diagnostic and therapeutic cases: case 2. thymoma and tumor lysis syndrome in an adolescent,” Journal of Clinical Oncology, vol. 22, no. 5, pp. 955–957, 2004. View at Google Scholar · View at Scopus
- L. M. Minasian, T. P. Szatrowski, M. Rosenblum et al., “Hemorrhagic tumor necrosis during a pilot trial of tumor necrosis factor- α and anti-GD3 ganglioside monoclonal antibody in patients with metastatic melanoma,” Blood, vol. 83, no. 1, pp. 56–64, 1994. View at Google Scholar · View at Scopus
- M. P. Castro, J. VanAuken, P. Spencer-Cisek, S. Legha, and R. W. Sponzo, “Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature,” Cancer, vol. 85, pp. 1055–1059, 1999. View at Google Scholar
- J. Stoves, D. Richardson, and H. Patel, “Tumour lysis syndrome in a patient with metastatic melanoma treated with biochemotherapy,” Nephrology Dialysis Transplantation, vol. 16, no. 1, pp. 188–189, 2001. View at Google Scholar · View at Scopus
- G. S. Habib and W. R. Saliba, “Tumor lysis syndrome after hydrocortisone treatment in metastatic melanoma: a case report and review of the literature,” American Journal of the Medical Sciences, vol. 323, no. 3, pp. 155–157, 2002. View at Google Scholar · View at Scopus
- K. J. Busam, J. Wolchok, A. A. Jungbluth, and P. Chapman, “Diffuse melanosis after chemotherapy-induced tumor lysis syndrome in a patient with metastatic melanoma,” Journal of Cutaneous Pathology, vol. 31, no. 3, pp. 274–280, 2004. View at Publisher · View at Google Scholar · View at Scopus
- Y. Nakamura, Y. Nakamura, E. Hori et al., “Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma,” International Journal of Dermatology, vol. 48, no. 7, pp. 763–767, 2009. View at Publisher · View at Google Scholar · View at Scopus
- E. Borne, R. Serafi, F. Piette, and L. Mortier, “Tumour lysis syndrome induced by corticosteroid in metastatic melanoma presenting with initial hyperkalemia,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 7, pp. 855–856, 2009. View at Publisher · View at Google Scholar · View at Scopus
- S. Schuman, J. M. Pearson, J. A. Lucci, and L. B. Twiggs, “Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report,” Journal of Reproductive Medicine for the Obstetrician and Gynecologist, vol. 55, no. 10, pp. 441–444, 2010. View at Google Scholar · View at Scopus
- C. D. Blanke, M. P. A. Hemmer, and R. S. Witte, “Acute tumor lysis syndrome with choriocarcinoma,” Southern Medical Journal, vol. 93, no. 9, pp. 916–919, 2000. View at Google Scholar · View at Scopus
- G. Feres, J. I. Salluh, C. Ferreira, and M. Soares, “Severe acute tumor lysis syndrome in patients with germ-cell tumors,” Indian Journal of Urology, vol. 24, no. 4, pp. 555–557, 2008. View at Publisher · View at Google Scholar · View at Scopus
- R. D. W. Hain, L. Rayner, S. Weitzman, and A. Lorenzana, “Acute tumour lysis syndrome complicating treatment of stage IVS neuroblastoma in infants under six months old,” Medical and Pediatric Oncology, vol. 23, no. 2, pp. 136–139, 1994. View at Publisher · View at Google Scholar · View at Scopus
- B. H. Kushner, M. P. LaQuaglia, S. Modak, and N. K. V. Cheung, “Tumor lysis syndrome, neuroblastoma, and correlation between serum lactate dehydrogenase levels and MYCN-amplification,” Medical and Pediatric Oncology, vol. 41, no. 1, pp. 80–82, 2003. View at Publisher · View at Google Scholar · View at Scopus
- G. C. Tomlinson and L. A. Solberg, “Acute tumor lysis syndrome with metastatic medulloblastoma. A case report,” Cancer, vol. 53, no. 8, pp. 1783–1785, 1984. View at Google Scholar · View at Scopus
- L. Baeksgaard and J. B. Sorensen, “Acute tumor lusis syndrome in solid tumors—a case report and review of the literature,” Cancer Chemotherapy and Pharmacology, vol. 51, pp. 187–192, 2003. View at Google Scholar
- J. E. Gold, S. C. Malamud, F. LaRosa, and M. E. Osband, “Adoptive chemoimmunotherapy using ex vivo activated memory T-cells and cyclophosphamide: tumor lysis syndrome of a metastatic soft tissue sarcoma,” American Journal of Hematology, vol. 44, no. 1, pp. 42–47, 1993. View at Google Scholar · View at Scopus
- J. Khan and V. A. Broadbent, “Tumor lysis syndrome complicating treatment of widespread metastatic abdominal rhabdomyosarcoma,” Pediatric Hematology and Oncology, vol. 10, no. 2, pp. 151–155, 1993. View at Google Scholar · View at Scopus
- K. Q. Qian, H. Ye, Y. W. Xiao, Y. Y. Bao, and C. J. Qi, “Tumor lysis syndrome associated with chemotherapy in primary retroperitoneal soft tissue sarcoma by ex vivo ATP-based tumor chemo-sensitivity assay (ATP-TCA),” International Journal of General Medicine, vol. 2, pp. 1–4, 2009. View at Google Scholar · View at Scopus
- Y. Hiraizumi, S. Kamoy, Y. Inde, K. Kurose, Y. Ohaki, and T. Takeshita, “A case of tumor lysis syndrome following chemotherapy for a uterine epithelioid leiomyosarcoma with focal rhabdomyosarcomatous differentiation,” The Journal of Obstetrics and Gynaecology Research, vol. 37, pp. 1–6, 2011. View at Google Scholar
- A. Will and E. Tholouli, “The clinical management of tumour lysis syndrome in haematological malignancies,” British Journal of Haematology, vol. 154, no. 1, pp. 3–13, 2011. View at Publisher · View at Google Scholar · View at Scopus
- M. R. Zonfrillo, “Management of pediatric tumor lysis syndrome in the emergency department,” Emergency Medicine Clinics of North America, vol. 27, no. 3, pp. 497–504, 2009. View at Publisher · View at Google Scholar · View at Scopus
- R. Seth and A. S. Bhat, “Management of common oncologic emergencies,” Indian Journal of Pediatrics, vol. 78, no. 6, pp. 709–717, 2011. View at Publisher · View at Google Scholar · View at Scopus